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Abbreviations 
 
ACP amorphous calcium phosphate  
CCTOP Constrained Consensus Topology prediction  
CSF cerebrospinal fluid  
ER endoplasmic reticulum  
Fam20 Family with sequence similarity 20  
Fj Four-jointed  
FGF23 Fibroblast growth factor 23  
GO gene onthology  
HILIC hydrophilic interaction liquid chromatography  
HMGB1 high mobility group box 1 protein  
IMAC immobilized metal affinity chromatography  
OPN  osteopontin 
PTM post-translational modification 
SCX strong cation exchange chromatography  
SIBLING small integrin-binding ligand N-linked glycoprotein  
TMT  Tandem Mass Tag 
VLK vertebrate lonesome kinase  
  
4 
 
Summary 
 
The very existence of extracellular phosphorylation has been questioned for a long time, although casein 
phosphorylation was discovered a century ago. In addition, several modification sites localized on 
secreted proteins or on extracellular or lumenal domains of transmembrane proteins have been 
catalogued in large scale phosphorylation analyses, though in most such studies this aspect of cellular 
localization was not considered. Our review presents examples when additional analyses were performed 
on already public datasets that revealed a wealth of information about this "neglected side" of the 
modification. We also sum up accumulated knowledge about extracellular phosphorylation, including the 
discovery of Golgi-residing kinases and the special difficulties encountered in targeted analyses. We hope 
future phosphorylation studies will not ignore the existence of phosphorylation outside of the cell, and 
further discoveries will shed more light on its biological role.  
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Phosphorylation is the main regulatory modification of intracellular proteins and is involved in the majority 
of cellular processes. The existence of this modification extracellularly has long been disputed despite the 
fact that caseins abundant in milk were the first phosphoproteins discovered in the late 1800s [1]. 
Gradually, other secreted proteins and peptide hormons were reported to contain this modification. 
Recently (as of November 3, 2015) the UniProt database [2] yielded 131 proteins once the entries were 
filtered using the following criteria: species - homo sapiens; subcellular localization – secreted; post-
translational modification (PTM) – phospho*; and all of these were ’reviewed’ (Supplemental Table 1). 
Approximately, ¾ of these proteins are indeed in vivo modified on an amino acid side-chain that normally 
is localized ’outside’ of the cell. The lumenal side of the endoplasmic reticulum (ER) or the Golgi are also 
considered as such. The accumulating evidence slowly changed the old dogma that restricted 
phosphorylation to the intracellular milieu, yet, our understanding of the regulation and the exact role of 
the modification on extracellular proteins is still very limited.  
 
Are these proteins secreted phosphorylated or modified extracellularly? 
In the classical secretion pathway a short signal sequence directs the protein to the ER, then the protein 
travels through the Golgi network and is finally released to the extracellular space. During this transport 
the protein may undergo post-translational modifications. Specific kinase activity distinct from cytoplasmic 
kinases was detected in the Golgi apparatus isolated from lactating mammary gland, liver, spleen and 
other organs [3,4]. This kinase was shown to phosphorylate proteins on an S-x-E/pS motif; resist inhibitors 
of other protein kinases; use Mn
2+
 as activator instead of Mg
2+
; and ATP but not GTP as the phosphate 
donor [4]. However, this kinase escaped identification for a long time. The first Golgi-residing kinase Four-
jointed (Fj) was identified in Drosophila [5]. Fj was shown to phosphorylate cadherin domains of the 
transmembrane proteins Fat and Dachsous, yet with different site specificity. PSI-BLAST (Position-
Specific Iterated Basic Local Alignment Search Tool) search performed with the human orthologue of Fj, 
Fjx1 identified Family with sequence similarity 20 (Fam20) and 198 (Fam198) members as other potential 
Golgi kinases [6]. Eventually, protein Fam20C was identified as ‘the real casein kinase’ featuring all the 
characteristics described decades earlier, as listed above. It resides in the Golgi but it can also be found in 
an N-terminally truncated, secreted form [6,7]. Phosphorylation of the substrate proteins occurs 
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intracellularly [7,8], yet Fam20C may exert its activity also extracellularly. Fam20C was demonstrated to 
phosphorylate a wide array of secreted proteins involved in biomineralization, lipid homeostasis, wound 
healing, cell adhesion and migration [7]. 
Another newly identified kinase: vertebrate lonesome kinase (VLK) - which shows preference for Tyr 
residues - also localizes in the secretory pathway [9,10]. High expression level of VLK was detected in 
platelets, and upon stimulation by the thrombin receptor activating peptide (TRAP) VLK was rapidly and 
quantitatively released from platelets. Besides phosphorylating substrate proteins in the secretory 
pathway, secreted VLK was found to modify targets in the extracellular environment. Though numerous 
substrates of VLK were identified, no consensus motif could be determined [10]. 
Other kinases have also been observed in the releasate of activated platelets that can perform 
phosphorylation of extracellular proteins if sufficient ATP is available. Platelet secreted casein kinase(s) 
were shown to phosphorylate protein S and this phosphorylation enhanced its activated protein C cofactor 
activity thereby affecting its anticoagulant property [11]. Upon stimulation by thrombin a cAMP-dependent 
protein kinase (PKA) was released from platelets which phosphorylated vitronectin [12]. Several protein 
kinase C isozymes were also found secreted upon thrombin stimulation from platelets [13]. 
Proteins lacking a signal peptide and thus not entering the classical ER/Golgi secretion pathway may be 
released to the extracellular space by unconventional means of protein export, either via direct membrane 
translocation or secretion in various vesicules [14]. In the secretome analysis of MCF7 human breast 
cancer cell line it was found that only half of the detected proteins were secreted via the classical ER/Golgi 
pathway or shed by plasma membrane, the other half of the proteins used unconventional secretion [15]. 
Intracellular phosphorylation of these proteins may precede their export. Actually, in certain cases it was 
demonstrated that phosphorylation is a prerequisite for the transport. Fibroblast growth factor 2 (FGF2) is 
secreted by direct translocation across plasma membranes and its phosphorylation at Tyr-82 by Tec 
kinase is required for the secretion [16]. Heat stress-induced translocation of annexin 2 is dependent on 
Tyr-23 phosphorylation [17]. The high mobility group box 1 protein (HMGB1) is a DNA chaperone that acts 
also extracellularly in the regulation of inflammation. Phosphorylation of HMGB1 in its nuclear localization 
signal (NLS) regions results in the relocation of the protein from the nucleus to the cytoplasm with 
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consecutive secretion [18]. However, it should be noted that detection of phosphoproteins or kinase 
activities outside the cell may also be an artifact from broken cells and thus, not physiologically relevant. 
 
Large scale MS analyses significantly contribute to extracellular phosphorylation data accumulation 
Most information on the phosphorylation of extracellular proteins may be retrieved from mass 
spectrometric data. Large scale analyses of tissues or whole cells are a major source of such data. 
Interestingly, the resulting huge datasets practically are never interrogated for the subcellular localization 
of the modification, and the extracellular phosphorylation sites detected are not reported separately. That 
is a pity, since such information has been available for years and has been mostly ignored. For a few 
datasets we performed this analysis with the following notices: i) we accepted the reported 
phosphorylation data at face value, ii) we somewhat trusted the UniProt cellular localization labels, iii) 
proteins secreted via alternative pathways were kept, iv) proteins that localize to the ER/Golgi were 
subjected to topology prediction using the Constrained Consensus Topology prediction method (CCTOP, 
http://cctop.enzim.ttk.mta.hu) [19] and only proteins with lumenal modification sites were kept. 
Many plasma proteins are synthesized in hepatocytes, therefore, the in-depth phosphoproteome analysis 
of a liver homogenate performed by Bian et al. proved to be a rich source of extracellular phosphorylation 
data [20]. Their workflow of „enzyme-assisted” two dimensional reversed phase chromatography 
supplemented with phosphopeptide enrichment using Ti(IV)-immobilized metal affinity chromatography 
(IMAC) resulted in phosphosite mapping of 54 secreted and 51 ER- or Golgi-localized proteins with 
lumenal phosphorylation sites (Supplemental Table 2). Similarly, large amount of extracellular 
phosphorylation data could be retrieved from the analysis of breast cancer xenograft (human on mouse) 
and human ovarian tumor samples performed by Mertins et al. [21]. Combined, 489 secreted and 275 
ER/Golgi-residing phosphoproteins were identified in that study using high pH reversed phase 
fractionation followed by Fe(III)-IMAC phosphopeptide enrichment and LC-MS/MS analysis (Supplemental 
Table 3). Strong cation exchange chromatography (SCX) with consecutive TiO2 enrichment performed by 
Sharma et al. in the analysis of a human cancer cell line also yielded extensive phosphoproteome 
coverage [22]. Actually, the authors of this study paid some attention to extracellular phosphorylation. 
However, only Fam20C phosphorylation was considered within S-x-E/pS motifs and Pro was not permitted 
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in the ’middle’ position. Their search yielded 101 phosphosites on 64 proteins. Unfortunately, modification 
within a 3-amino-acid-constrain does not guarantee the identification of the kinase responsible. The 
authors did not check whether the regions modified ever enter the ER/Golgi system, and thus, the list 
contains numerous cytoplasmic modification sites that were possibly phosphorylated by kinases other 
than Fam20C. For example, Golgin subfamily B member 1 (UniProt Q14789-2) was included in the list 
with phosphorylated Ser-128, 139, 676, 1756, 1758 and 3145. Except, according to the protein’s topology 
all of these sites are located in the cytoplasmic domain (positions: 1-3235). Our re-evaluation which was 
not restricted to Fam20C phosphorylation revealed 71 secreted and an additional 90 ER/Golgi-resident 
phosphoproteins in their study (Supplemental Table 4).  
 
Extracellular phosphorylation analysis from cell culture media 
Though whole cell analyses may contain extensive data on the phosphorylation of secreted proteins more 
specific information can be extracted from targeted analyses that use the culture media of specific cell 
lines. Tagliabracci et al. compared the phosphoproteome of wild type and Fam20C knockout/knockdown 
HepG2 liver cells secreted into the cell culture media [7]. As Fam20C shows high expression level in 
lactating mammary gland and mineralized tissue, their analyses were extended to breast epithelial and 
osteoblast-like cell lines to map modification sites that are linked to the Fam20C kinase activity. Applying 
Fe(III)-IMAC phosphopeptide enrichment, over 100 secreted phosphoproteins were identified in the 
culture media of these cell lines and the majority of the modification sites responded to Fam20C depletion. 
Interestingly, about ⅓ of the phosphosites whose intensity faded upon Fam20C depletion did not match 
the consensus S-x-E/pS sequence. Phosphosite mapping of insulin-like growth factor-binding protein 1 in 
vitro phosphorylated by Fam20C also indicated modifications in non-S-x-E/pS motives. The authors 
speculated that the recognition motif of Fam20C might be significantly broader than originally suspected, 
however, kinase assays performed with synthetic peptides could extend Fam20C activity only to S-x-Q-x-
x-D/E-D/E-D/E sequences present in proline-rich phosphoprotein 1 (PRP1) [7,23]. In addition, one has to 
consider the potential existence of ‘phosphorylation cascades’ in the Golgi where the elimination of a 
kinase affects not only the direct substrates but also all the ‘downstream’ modifications. 
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Cancer cells are known to display differences in intercellular communication or in their cell adhesion and 
migration properties that might partially be due to changes in the phosphorylation pattern of the proteins 
secreted into their microenvironment. In a phosphorylation analysis of the secretome of different luminal 
and basal type breast cancer cell lines over 1700 phosphoproteins were identified altogether combining 
hydrophilic interaction liquid chromatography (HILIC) with TiO2 phosphopeptide enrichment [24]. 
Approximately half of these phosphoproteins were predicted to be extracellular or membrane proteins 
according to gene onthology (GO) annotation and bioinformatics analyses using SignalP (classical 
secretion), SecretomeP (unconventional secretion) and TMHMM (transmembrane domains) algorithms. 
The proteins that showed subtype specific phosphorylation sites were involved among others in cell 
signaling and interaction, antigen presentation or cellular assembly and organisation. 
 
Analytical challenges in extracellular phosphorylation studies 
While the secretome can be studied from the culture media of different cell lines, phosphorylation analysis 
directly from readily available body fluids has the most potential in the clinic. There is only a limited 
number of such reports yet and the phosphorylation data derived from these studies are far from those 
targeting intracellular phosphorylation. In cerebrospinal fluid (CSF) 25-45 phosphoproteins were identified 
from 60-200 μg starting material combining SCX fractionation with phosphoSer specific molecularly 
imprinted polymers or using TiO2 enrichment [25,26]. Plasma/serum phosphoproteome analyses fared 
even worse in this aspect, 40-100 μl of plasma (~2-5 mg protein) yielded 30-70 phosphoproteins using 
TiO2 enrichment (either alone or in combination with SCX) or Fe(III)-IMAC [27-29]. The largest 
phosphopeptide dataset from plasma was reported by Zawadzka et al. in parallel to the breast cancer cell 
line secretome analysis [24]. On average, 130 phosphoproteins could be identified from 1 ml plasma (~50 
mg protein) of control or breast cancer patients using HILIC fractionation in combination with TiO2 
enrichment. Phosphorylation analysis of saliva also yielded moderate results, a total of 85 
phosphoproteins were identified from ~50 mg protein after SCX fractionation and Fe(III)-IMAC 
phosphopeptide enrichment [30].  
One of the main reasons for the relatively low outcome in the phosphorylation analysis of body fluids is the 
low level of the modification and the complexity and high dynamic range of proteins present in such 
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matrices. Immunodepletion was used in some cases for the removal of up to the fourteen most abundant 
plasma proteins to increase the depth of the analysis [24,25,28]. However, comparison of TiO2 enrichment 
applied to serum with or without depletion of albumin and IgG showed considerable loss of 
phosphopeptides in the depleted fraction [27]. Depletion of the highly abundant proteins was also found 
detrimental in the phosphoproteome analysis of CSF [26]. Indeed, off-target removal was reported using 
albumin-specific and other immunodepletion kits [31-33]. This may be due to the role of albumin as a 
cargo for various compounds or a result of nonspecific binding to the affinity matrix. Additionally, ten of the 
fourteen proteins targeted by the MARS-14 column are actually phosphorylated [29]. Hexapeptide bead 
libraries (Proteominer) provide another means to narrow down the dynamic range, and that was used in 
the saliva phosphoproteome analysis by Stone et al. [30]. This approach, however, may distort the 
quantitative results. 
A highly efficient enrichment pipeline is a prerequisite for successful phosphorylation analysis from such 
complex matrices like serum. Above examples show a repertoire of available tools developed for the 
isolation of phosphopeptides. The most preferred ones are metal affinity techniques: TiO2 and IMAC often 
in combination with other orthogonal separations. Though very powerful, selectivity of these methods in 
CSF or serum is far below that reported for whole cell lysates. In the latter selectivity as high as 90% could 
be achieved [34] whereas in body fluids selectivity is rather around 30-60% [26, 27,29], a consequence of 
the high dynamic range and the overall low extent of the modification. Additionally, TiO2 and recently also 
IMAC was shown to isolate sialylated glycopeptides under certain conditions [35,36,29]. In the HeLa 
phosphopeptide dataset obtained after SCX fractionation and subsequent TiO2 enrichment, discussed 
earlier [22], 12.5% of the MS/MS spectra contained glycan specific oxonium ion (m/z 204.087, HexNAc) 
[37]. N-glycosylation is the most frequent and highly abundant modification on secreted and membrane 
proteins, thus, an even higher glycopeptide contribution is expected when extracellular or membrane 
proteins are probed. Approximately 1/3 of the MS/MS spectra contained glycan specific oxonium ions in 
datasets obtained after Fe(III)-IMAC phosphopeptide enrichment of serum [38,29]. Glycopeptides interfere 
with the phosphorylation analysis at multiple levels. First, glycopeptides affect enrichment efficiency by 
competing for the active sites of the affinity material. Second, co-elution of glycopeptides can lead to 
undersampling of the phosphopeptides in the LC-MS analysis of the enriched fraction. In selected cases 
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this interference of the glycopeptides was taken into account. In the CSF analysis Bahl et al. [26] removed 
N-glycans by peptide N-glycosidase F treatment prior to phosphopeptide enrichment. As deglycosylation 
may have an adverse effect on protein solubility, it should be performed on the digested sample. 
Deglycosylation, however, could be cost-prohibitive especially when large amounts of serum samples are 
processed. Additionally, upon removal of the N-glycans the Asn residues are converted to Asp increasing 
the acidic character of the peptide that can induce nonspecific binding to the affinity material. For IMAC we 
demonstrated that high acetonitrile containing solvents promote glycopeptide binding to the sorbent in a 
mixed mode of metal affinity and hydrophilic interaction [29]. Elimination of this latter component by 
lowering the acetonitrile content or replacing acetonitrile with methanol – a strong solvent in HILIC – 
abolished glycopeptide capture completely. TiO2 enrichment is also performed in solvents with high 
acetonitrile ratio, therefore, a similar mixed mode of metal affinity and hydrophilic interaction is expected in 
the capture of the glycopeptides to this sorbent.  
 
Bioinformatics challenges 
Large scale phosphopeptide datasets are processed in an automated fashion and the database search 
results rarely undergo manual validation. Whether a spectrum contains sufficient information for 
modification site assignment is MS/MS activation and sequence specific. Even if the phosphopeptide is 
identified correctly, reliability of the site assignment can be questionable, especially if multiple Ser/Thr 
residues are in close proximity. In such cases often all sites are reported as modified that calls for some 
caution when handling large scale mass spectrometric data. Development of additional bioinformatic tools 
that calculate probability of site assignments using prior search outputs [39-42] or direct integration of a 
scoring algorithm into the search engine to measure the confidence of the modification site localization 
[43] led to an improvement in this respect. Although, presently only a single search engine, Protein 
Prospector indicates directly when there is no sufficient information for reliable site assignment. 
Additionally, there are recent initiatives to make all mass spectral data available. Despite of these 
initiatives, there are errors in public databases. In PhosphoSitePlus [44] over 1000 phosphoproteins are 
listed that according to UniProt or GO annotation may be considered extracellular or transmembrane 
proteins. Among the modification sites listed for these proteins the ratio of phosphorylated Tyr residues is 
12 
 
unusually high which may be a consequence that a large proportion of the information in this database 
was obtained from affinity enrichments using phosphoTyr antibodies but also reflects the uncertainties of 
site assignments. In addition, human or software fault may introduce errors in curated lists. For example, 
Tyr-225 in osteopontin and Tyr-158 in insulin-like growth factor-binding protein 1 were incorrectly listed as 
Fam20C phosphorylation sites in the UniProt database, although these were originally detected TMT-
modified [7] (Supplemental Table 1). 
Even when the sequence identification as well as the site assignments are correct we may not know 
where the modified protein actually came from. In this aspect we may rely on ’Subcellular localization’ 
information from the UniProt database and/or GO annotations, but the available information varies. For 
certain entries the localization is straightforward, such as „Golgi apparatus membrane; Single-pass type I 
membrane protein”. But more frequently, this information line reads like a complete list of potential cellular 
localizations, including everything from the nucleus to the extracellular space. There are numerous 
proteins where this diverse localization list reflects known translocations. For example, as mentioned 
above HMGB1 indeed may occur in the nucleus as well as in the cytoplasm, and also secreted. However, 
this uncertainty about the ‘origin of the protein’ certainly hinders the characterization of subcellular 
localization-specific modifications. 
Last but not least for the characterization of extracellular phosphorylation the topology of the membrane 
proteins has to be considered. Luckily, such prediction-based information has been available for several 
proteins, and is regularly listed in UniProt. In a previous large scale glycosylation study we found this 
information very reliable, we encountered only 2 examples among hundreds of assignments that indicated 
glycosylation on a predicted cytoplasmic domain [45]. Also, there are several topology prediction servers 
available to assess potential localization of the modification sites, of which CCTOP was used here for 
topology prediction of the ER/Golgi-resident phosphoproteins. 
 
Biological significance of the modification 
Improved analytical methodologies continuously expand the class of secreted phosphoproteins leaving 
clarification of the biological importance of the modification far behind. The most established role of 
extracellular phosphorylation is related to the formation of the mineralized tissue. The structural matrix of 
13 
 
bones and teeth is made up of collagen. The different aspects of collagen phosphorylation on processing, 
fibril formation or protein interactions have recently been reviewed [46]. Other non-collagenous 
extracellular matrix proteins are also crucial in bone and tooth formation via the control of hydroxyapatite 
crystallization [47,48]. These secretory calcium-binding phosphoproteins (osteopontin, OPN; dentin matrix 
protein-1, DMP1; bone sialoprotein, BSP; matrix extracellular phosphoglycoprotein, MEPE and dentin 
sialophosphoprotein, DSPP) belong to the small integrin-binding ligand N-linked glycoprotein (SIBLING) 
family and are heavily phosphorylated [49]. Abnormal phosphorylation of these proteins is implicated in 
severe bone or tooth defects [6,50]. OPN is the most extensively studied member of the SIBLING family. 
The majority of its Ser residues (37 of 42 in human OPN) and a few Thr residues are reported to be 
phosphorylated, more than half of these being targets of the Fam20C kinase. The phosphorylated 
residues are mainly found in clusters and highly conserved in mammals [51,52]. OPN shows a variety in 
PTMs and processing that is linked to its diverse biological functions. Besides its essential role in inhibiting 
bone mineralization, it is involved in cell attachment and signaling, inflammation or tumorigenesis [52,53].  
Milk caseins are also related to the secretory calcium-binding phosphoproteins [54,55]. Phosphoserine 
clusters within -S-S-S-E-E- sequences (called phosphate centers) present in αs1-, αs2- and β-caseins show 
high affinity for calcium resulting in sequestration of amorphous calcium phosphate (ACP) [56]. The 
formed nanoclusters with a core of ACP surrounded by casein molecules assemble to casein micelles. 
These structures ensure supersaturation of calcium and phosphate in milk without calcification [57,58]. 
Similar sequestration of ACP as calcium phosphate nanoclusters was demonstrated for OPN peptides 
suggesting that such nanoclusters of other secreted phosphoproteins might be involved in the inhibition of 
calcification in soft and mineralized tissues, the extracellular matrix or biofluids [59]. 
Phosphorylation analyses performed on plasma/serum samples revealed the modification predominantly 
on proteins involved in blood coagulation, lipid transport and homeostasis, complement activation, 
proteolysis, cell adhesion and signaling [27-29]. The details, however, how the modification affects these 
processes are largely unknown. Recently, phosphorylation of Fibroblast growth factor 23 (FGF23) at Ser-
180 was demonstrated to inhibit glycosylation at Thr-178 in the subtilisin-like proprotein convertase 
cleavage region thereby affecting secretion of the full length biologically active hormone that regulates 
phosphate retention in the kidney [60,61]. Thus, phosphate level in the circulation is balanced by the 
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cross-talk of glycosylation, phosphorylation and proteolytic processing of FGF23. Previously, 
phosphorylation of factor XI by a platelet derived kinase was shown to increase its susceptibility to 
cleavage by factor XIIa or thrombin [62] suggesting a possible regulation of the coagulation cascade.  
 
Conclusions and perspectives 
Large scale phosphoproteomic analyses predominantly from whole cell lysates or conditioned media led 
to an expansion of extracellular phosphorylation data, although the general public is not aware of it yet. 
Properly cataloguing such data in public databases would facilitate our understanding what functions this 
PTM fulfills outside the cell. Currently, the PhosphoSitePlus database has the largest collection of 
phosphorylation data. This list can be interrogated on the protein level about cellular localization.  
Unfortunately, results from the direct analysis of biofluids are limited due to the extreme dynamic range in 
these matrices that currently limits MS-based phospho-screening of biofluids. However, there are initial 
attempts to find biomarker candidates in plasma or to assess variation in the phosphorylation level of 
plasma phosphoproteins [24,63]. Continuous improvements in MS detection sensitivity will facilitate 
detection of lower abundance phosphoproteins. Yet, it is a question how deep we can dig in this huge 
dynamic range especially when unexpected post-translationally or artificially (due to sample handling) 
modified counterparts of the higher abundance components reach the level of low abundance proteins 
and further increase complexity. In addition, it has also been reported that using a single enrichment 
protocol reveals only a portion of the ‘phosphoproteome’ [64-66]. Perhaps, the combined effort of multiple 
groups could deliver almost comprehensive results. 
Within the cell phosphorylation is a highly regulated process with a concerted action of a plethora of 
kinases and phosphatases affecting the vast majority of intracellular proteins. The lower abundance of 
extracellular phosphorylation and the limited number of kinases and phosphatases detected outside the 
cell doubt such a control extracellularly. However, the wealth of extracellular phosphorylation data and 
also recent targeted analyses anticipate discovery of further secretory pathway kinases [67]. Deciphering 
the actual roles of the modification on extracellular proteins is also urgently needed to clear this puzzling 
picture. 
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